Recherche - Université de Picardie Jules Verne Accéder directement au contenu

Filtrer vos résultats

10 Résultats
authFullName_s : Guillaume Martin-Blondel

Cerebral perfusion using ASL in patients with COVID-19 and neurological manifestations: A retrospective multicenter observational study

François-Daniel Ardellier , Seyyid Baloglu , Magdalena Sokolska , Vincent Noblet , François Lersy , et al.
Journal de Neuroradiologie / Journal of Neuroradiology, 2023, ⟨10.1016/j.neurad.2023.01.005⟩
Article dans une revue hal-03958604v1
Image document

Prevalence of Post-Acute COVID-19 Symptoms Twelve Months after Hospitalisation in Participants Retained in Follow-up: Analyses Stratified by Gender from a Large Prospective Cohort

Jade Ghosn , Delphine Bachelet , Marine Livrozet , Minerva Cervantes-Gonzalez , Julien Poissy , et al.
Clinical Microbiology and Infection, 2023, 29 (2), pp.254.e7-254.e13. ⟨10.1016/j.cmi.2022.08.028⟩
Article dans une revue hal-03801797v1

Brain MRI Findings in Severe COVID-19: A Retrospective Observational Study

Stéphane Kremer , François Lersy , Jérome de Sèze , Jean-Christophe Ferré , Adel Maamar , et al.
Radiology, 2020, 297 (2), pp.E242-E251. ⟨10.1148/radiol.2020202222⟩
Article dans une revue inserm-03482261v1

Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19

Yoann Zerbib , Yazdan Yazdanpanah , Guilhem Wattecamps , Florent Wallet , Gil Verschelden , et al.
The Lancet Infectious Diseases, 2022, 22 (6), pp.764-765. ⟨10.1016/S1473-3099(22)00295-X⟩
Article dans une revue hal-03687787v1

An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

Florence Ader , Nathan Peiffer-Smadja , Julien Poissy , Maude Bouscambert-Duchamp , Drifa Belhadi , et al.
Clinical Microbiology and Infection, 2021, 27 (12), pp.1826-1837. ⟨10.1016/j.cmi.2021.05.020⟩
Article dans une revue hal-03364426v1
Image document

COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study

Sheryl Ann Abdukahil , Ali Ait Hssain , Younes Ait Tamlihat , Kazali Enagnon Alidjnou , Carlos Alexandre Antunes de Brito , et al.
Infection, 2021, 49 (5), pp.889-905. ⟨10.1007/s15010-021-01599-5⟩
Article dans une revue hal-03273644v1

Impact on disease mortality of clinical, biological, and virological characteristics at hospital admission and overtime in COVID‐19 patients

Yazdan Yazdanpanah , Alpha Diallo , Christelle Paul , Noémie Mercier , Soizic Le Mestre , et al.
Journal of Medical Virology, 2021, 93 (4), pp.2149-2159. ⟨10.1002/jmv.26601⟩
Article dans une revue hal-04121463v1
Image document

Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the DisCoVeRy randomised, controlled, open-label trial

Florence Ader , Maude Bouscambert-Duchamp , Maya Hites , Nathan Peiffer-Smadja , Julien Poissy , et al.
2023
Pré-publication, Document de travail hal-04117589v1

Antiviral drugs in hospitalized patients with COVID-19 - the DisCoVeRy trial

Florence Ader , Nathan Peiffer-Smadja , Julien Poissy , Maude Bouscambert-Duchamp , Drifa Belhadi , et al.
2023
Pré-publication, Document de travail hal-04118710v1

Remdesivir for the Treatment of Hospitalised Patients with COVID-19 (DisCoVeRy): A Randomised, Controlled, Open-Label Trial

Florence Ader , Maude Bouscambert-Duchamp , Maya Hites , Nathan Peiffer-Smadja , Julien Poissy , et al.
SSRN Electronic Journal, 2021, ⟨10.2139/ssrn.3854628⟩
Article dans une revue hal-04119314v1